J. Barbera (Barcelona, Spain), R. Naeije (Brussels, Belgium)
A single pathogenetic mechanism for vascular remodeling and inflammation in PAH
S. Hamidi, A. Szema, S. Said (Stony Brook, NY, Northport, NY, United States Of America)
|   |
Identification of target antigens of anti-fibroblast antibodies in pulmonary arterial hypertension
M. Tamby, B. Terrier, L. Camoin, P. Guilpain, C. Broussard, G. Bussone, A. Yaici, F. Hotellier, G. Simonneau, L. Guillevin, M. Humbert, L. Mouthon (Paris, Clamart, France)
| |
Hypoxia-dependent Fhl-1 regulation leads to proproliferative effects in PASMC
G. Kwapiszewska, M. Wygrecka, L. Marsh, S. Schmitt, R. Troesser, A. Zakrzewicz, W. Seeger, O. Eickelberg, L. Fink, N. Weissmann (Giessen, Germany)
| |
Dysregulated bone morphogenetic protein signaling in pulmonary arterial hypertension
L. Dewachter, E. Marcos, E. Fadel, L. I. Tu, P. Zadigue, S. Adnot, M. Humbert, R. Naeije, S. Eddahibi (Paris, Clamart, Le Plessis Robinson, France; Bruxelles, Belgium)
| |
Endothelin-1 inhibits TASK-1 in human pulmonary artery smooth muscle cells via phospholipase C-diacylglycerol-protein kinase C-pathway
B. Tang, Y. Li, N. Chandran, K. Katharina, S. Gabor, H. Popper, H. Olschewski, A. Olschewski (Graz, Austria)
| |
Effects of BMPR-II signal transduction in the pulmonary vascular remodeling of monocrotaline induced pulmonary hypertension in rats
T. Kuang, C. Wang, B. Pang, J. Wang (Beijing, China)
| |
Bosentan combined with sildenafil prevents right ventricular hypoxia in pulmonary arterial hypertension
K. T. B. Mouchaers, Y. Y. Wong, I. Schalij, G. P. van Nieuw Amerongen, A. Vonk-Noordegraaf, W. J. van der Laarse (Amsterdam, Netherlands)
| |
Superoxide generation in pulmonary and systemic arterial smooth muscle cells and fibroblasts under hypoxic conditions
B. Fuchs, B. Ahmet, E. Bakytbek, R. Markus, S. Natascha, R. T. Schermuly, G. Hossein A., S. Werner, G. Friedrich, W. Norbert (Giessen, Germany)
| |
Alveolar hypoxia induces generation of IL-18 in mice. IL-18 reduces phosphorylation of the calcium handling protein phospholamban in cardiomyocytes
K. O. Larsen, B. Lygren, I. Sjaastad, K. A. Krobert, G. Florholmen, K. Arnkvaern, F. O. Levy, O. H. Skjonsberg, K. Tasken, G. Christensen (Oslo, Norway)
| |
Involvement of pulmonary artery smooth muscle cell apoptosis in simvastatin-induced regression of hypoxic pulmonary hypertension
A. Boueiz, S. Mozammel, P. Kesari, M. Crow, R. Johns, P. Hassoun, R. Girgis (Baltimore, MD, United States Of America)
| |
Functional expression of transient receptor potential vanilloid-related channels in chronically hypoxic human pulmonary arterial smooth muscle cells
Y. Wang, C. Wang, C. Wang, J. Wang (Beijing, China)
| |
Stable prostacyclin analogues treprostinil and iloprost activates KCa and two-pore domain TASK-1 channels in human pulmonary artery smooth muscle cells
Y. Li, B. Tang, N. Chandran, K. Leithner, F. M. Smolle-Juettner, E. Stacher, H. Olschewski, A. Olschewski (Graz, Austria)
| |
Vascular progenitor cells are subjected to epithelial to mesenchymal transition (EMT)-like during smooth muscle cell differentiation
M. M. Musri, M. Diez, J. A. Barberà, V. I. Peinado (Barcelona, Spain)
| |
Cigarette smoke upregulates endothelin B receptors in human pulmonary arteries
G. Juan, M. Ramon, I. Lluch, M. Losada, J. Milara, J. L. Ortiz, J. Cortijo, E. Morcillo (Valencia, Madrid, Spain; Valencia, Saint Vincent And The Grenadines)
| |
Phosphodiesterase 4 and 5 inhibitors decrease HO-1 and IL-8 gene expression induced by cigarette smoke
G. Juan, M. Ramon, I. Arroyo, J. Milara, J. L. Ortiz, E. Donet, J. Cortijo, E. Morcillo (Valencia, Madrid, Spain)
| |
Long term exposure to cigarette smoke associated with hypoxia promotes further development of pulmonary hypertension in the guinea pig
E. Ferrer, V. I. Peinado, J. Prieto-Lloret, M. Díez, M. V. Vega-Agapito, M. C. González-Martín, M. T. Agapito, A. Obeso, C. González, J. A. Barberà (Barcelona, Barcelona and Valladolid, Valladolid, Spain)
| |
Growth-differentiation factor-15 as a prognostic indicator in idiopathic pulmonary arterial hypertension
N. Nickel, T. Kempf, H. Golpon, K. Wollert, M. Wilkins, S. Gibbs, M. Hoeper (Hannover, Lower Saxony, Germany; London, United Kingdom)
| |
High-sensitive troponin T as a new biomarker and an indicator of disease severity in patients with pulmonary arterial hypertension
A. Filusch, E. Giannitsis, H. Katus, J. Meyer (Heidelberg, Georgia)
| |
Vascular wall remodeling in patients with chronic thromboembolic pulmonary hypertension: a role for C-reactive protein
M. Wynants, R. Quarck, E. Alfaro-Moreno, B. Meyns, M. Delcroix (Leuven, Belgium; Mexico City, Mexico)
| |